Publications by authors named "Chaojin Hong"

Claim this Profile
S
Synergistic Anticancer Effects of COL6A1 Downregulation and the PD1 Inhibitor Pembrolizumab in Bladder Cancer.
Fang Yuan, Xiangjie Li, Chaojin Hong, Xinmian Huang

J Biochem Mol Toxicol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies.
Jiahong Jiang, Luying Zhan, Boyang Jiang, Jingyi Pan, Chaojin Hong

Cancer Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulated CDK10 promotes cancer progression and radioresistance in lung cancer through activating the JNK/c-Jun signaling pathway.
Chaojin Hong, Yimei Meng, Anchen Qiu, Haibo Zhang, Liu Yang, Yupeng Hong

BMB Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of USP9X in cellular functions and tumorigenesis (Review).
Yimei Meng, Chaojin Hong, Sifu Yang, Zhiquan Qin, Liu Yang

Oncol Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent exon 19 deletion and comutation: a case report.
Zhiquan Qin, Hang Zhang, Peiyuan Yan, Lili Yu, Chaojin Hong

J Thorac Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of Cadherin2 in Thyroid Cancer.
Yun Chen, Chaojin Hong, Qihao Zhou, Zhiquan Qin

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis.
Yun Chen, Chaojin Hong, Jing Qu, Junjun Chen, Zhiquan Qin

Bioengineered· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer.
Zhi-Quan Qin, Si-Fu Yang, Yun Chen, Chao-Jin Hong, Tong-Wei Zhao

World J Clin Cases· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway.
Yun Chen, Chaojin Hong, Xiaochen Chen, Zhiquan Qin

Oncol Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study.
Tongwei Zhao, Ying Jin, Guangyun Mao, Yaping Wei, Guoqing Wu, Yupeng Hong, Chaojin Hong, Hongying Zhou

Medicine (Baltimore)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis